Immune Modulation by Misoprostol

NCT02259309 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Gynecological Infection

Interventions

DRUG: Misoprostol - buccal
DRUG: Misoprostol - vaginal

Sponsor

Vanderbilt University

Collaborators

[object Object]